☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Cognition Therapeutics
Cognition Therapeutics Reports P-II Study (SEQUEL) Results of CT1812 for Mild-to-Moderate Alzheimer’s Disease in Netherlands
June 29, 2023
Load more...
Back to Home
Modal title
×
Modal body text goes here.